Surveillance Improves Outcomes for Carriers of <i>SDHB</i> Pathogenic Variants: A Multicenter Study

Abstract

SDHB carriers with s-d tumors had smaller tumors, reduced risk of metastatic disease, and lower mortality than probands. Our results suggest that SDHB PV carriers should undertake surveillance to improve clinical outcomes.